Jason Adair
Chief Business Officer
Replay available
Liquidia Corporation (NASDAQ: LQDA) Q4 2025 earnings conference call, held 2026-03-05. Replay captured from the company's public earnings webcast.

Chief Business Officer
Chief Executive Officer
Chief Operating Officer and Chief Financial Officer
Analyst, Raymond James
Chief Commercial Officer
Chief Medical Officer
Analyst, Jefferies
Analyst, Needham & Company
Watch the replay and follow the connected company analysis, news, and investor updates for Liquidia Corporation.
WEBVTT 00:00:00.031 -- 00:00:05.176 Good morning and welcome to the Liquidia Corporation full year 2025 financial 00:00:05.176 -- 00:00:07.598 results and corporate update conference call. 00:00:07.598 -- 00:00:10.641 My name is Josh and I will be your operator today. 00:00:10.641 -- 00:00:13.304 All participants are currently in listen-only mode. 00:00:13.304 -- 00:00:16.727 Following the presentation, we will conduct a question and answer session. 00:00:16.727 -- 00:00:20.650 Instructions for joining the queue will be provided at that time. 00:00:20.650 -- 00:00:23.513 Please note that today's call is being recorded. 00:00:23.513 -- 00:00:29.077 I'll now turn the call over to Jason Adair, Chief Business Officer. 00:00:30.760 -- 00:00:34.484 Thank you and good morning, everyone. It's my pleasure to welcome you to our full year 00:00:34.484 -- 00:00:37.848 2025 financial results and corporate update call. 00:00:37.848 -- 00:00:42.273 Joining me today are Dr. Roger Jeffs, Chief Executive Officer, 00:00:42.273 -- 00:00:46.298 Michael Cassetta, Chief Operating Officer and Chief Financial Officer, Dr. 00:00:46.298 -- 00:00:51.324 Rajiv Sagar, Chief Medical Officer, Scott Mumaw, Chief Commercial Officer, and Rusty 00:00:51.324 -- 00:00:53.907 Schundler, our General Counsel. 00:00:53.907 -- 00:00:58.232 Before we begin, please note that today's discussion will include forward-looking statements, 00:00:58.232 -- 00:01:02.481 including statements regarding future results product performance, and ongoing clinical 00:01:02.481 -- 00:01:06.545 or commercial activities. These statements are subject to risks and uncertainties that 00:01:06.545 -- 00:01:09.589 may cause actual results to differ materially. 00:01:09.589 -- 00:01:15.035 For further information, please refer to our f...